Colon-26 Syngeneic | Rincon Bio

Rincon Bio performs Colon-26 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.

Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies

Colon-26 cells were derived from a BALB/c mouse. It is a colorectal cancer line and grows as a subcutaneous model

Receive a quote within one business day for a Colon-26 syngeneic study

WHY WORK WITH

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

Most efficacy studies can be initiated within two business days.

We love our clients. We develop a personal interest in our clients and their studies.